To determine the effect of inhibition of LOXs and specifically LOXL2 on tumor cells, the serum-stimulated proliferative response of HSC3 cells in the presence or absence of PXS-S1C or BAPN, which inhibits all LOX paralogues including LOXL2, was investigated. Here, LOXL2 is linked to neoplasm.